Cargando…

Further validation of the efficacy of mesenchymal stem cell infusions for reducing mortality in COVID-19 patients with ARDS

Recent double-blind, randomized, controlled trials reported that human umbilical cord-derived mesenchymal stem cell (MSC) infusions in COVID-19 patients with acute respiratory distress syndrome (ARDS) could diminish cytokine storm and lung damage. While these outcomes are significant, additional pha...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shetty, Ashok K., Shetty, Padmashri A., Zanirati, Gabriele, Jin, Kunlin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Comment
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8429629/ https://www.ncbi.nlm.nih.gov/pubmed/34504110 http://dx.doi.org/10.1038/s41536-021-00161-z

Ejemplares similares

Stem cell-based therapy for COVID-19 and ARDS: a systematic review
por: Zanirati, Gabriele, et al.
Publicado: (2021)

The Interstitial System of the Brain in Health and Disease
por: Shetty, Ashok K., et al.
Publicado: (2020)

Mesenchymal Stem Cell Infusion Shows Promise for Combating Coronavirus (COVID-19)- Induced Pneumonia
por: Shetty, Ashok K
Publicado: (2020)

Further proof of the plasticity of adult stem cells and their role in tissue repair
por: Prockop, Darwin J.
Publicado: (2003)

Intravenous immunoglobulin therapy for COVID-19 ARDS
por: Wilfong, Erin M, et al.
Publicado: (2022)

Combating COVID-19 With Mesenchymal Stem/Stromal Cell Therapy: Promise and Challenges
por: Wang, Shihua H., et al.
Publicado: (2021)

β-agonists for ARDS: the dark side of adrenergic stimulation?
por: Thompson, B Taylor
Publicado: (2012)

Interleukin-6 inhibitors in non-COVID-19 ARDS: analyzing the past to step into the post-COVID-19 era
por: Gandini, Lucia, et al.
Publicado: (2023)

Cytokine adsorption during ECMO for COVID-19-related ARDS
por: Shekar, Kiran, et al.
Publicado: (2021)

Mass gathering events and reducing further global spread of COVID-19: a political and public health dilemma
por: McCloskey, Brian, et al.
Publicado: (2020)

Higher PEEP in intubated COVID-19-associated ARDS patients? We are not sure
por: Yaroshetskiy, Andrey I., et al.
Publicado: (2022)

COVID-19-related ARDS: one disease, two trajectories, and several unanswered questions
por: Lascarrou, Jean-Baptiste
Publicado: (2021)

Why compliance and driving pressure may be inappropriate targets for PEEP setting during ARDS
por: Grieco, Domenico Luca, et al.
Publicado: (2022)

Novel paediatric presentation of COVID-19 with ARDS and cytokine storm syndrome without respiratory symptoms
por: Pain, Clare E, et al.
Publicado: (2020)

Time-controlled adaptive ventilation in patients with ARDS—lack of protocol adherence: a systematic review
por: Katzenschlager, Stephan, et al.
Publicado: (2023)

Group B streptococcus vaccines: one step further
por: Berner, Reinhard
Publicado: (2021)

Risking further COVID-19 waves despite vaccination
por: Contreras, Sebastian, et al.
Publicado: (2021)

Reducing child mortality in China: successes and challenges
por: Guo, Yan, et al.
Publicado: (2016)

Advances and challenges of mesenchymal stem cells for pregnancy-related diseases
por: Li, Yan-Hong, et al.
Publicado: (2021)

ECMO for severe ARDS associated with COVID-19: now we know we can, but should we?
por: Shekar, Kiran, et al.
Publicado: (2020)

Human milk banks: a need for further evidence and guidance
por: Fang, Mirriam Tyebally, et al.
Publicado: (2021)

Extracellular vesicles from human iPSC-derived neural stem cells: miRNA and protein signatures, and anti-inflammatory and neurogenic properties
por: Upadhya, Raghavendra, et al.
Publicado: (2020)

A further step towards the practical application of quantum computing in chemistry
por: Veis, Libor
Publicado: (2022)

Towards further harmonization of a glossary for exposure science—an ISES Europe statement
por: Heinemeyer, Gerhard, et al.
Publicado: (2021)

Pulpotomy versus root canal treatment in permanent teeth with spontaneous pain: comparable clinical and patient outcomes, but insufficient evidence
por: Afrashtehfar, Kelvin I., et al.
Publicado: (2023)

Commentary to: Hyperoxemia in postsurgical sepsis/septic shock patients is associated with reduced mortality
por: Guerrero-Gutiérrez, Manuel Alberto, et al.
Publicado: (2022)

COVID-19 challenges Brazil to comply with agenda 2030 to reduce maternal mortality
por: Guimarães, Raphael Mendonça
Publicado: (2023)

Genetic evaluation of mesenchymal stem cells
por: Afonso Cornélio, Déborah, et al.
Publicado: (2014)

Baricitinib in COVID-19: a coming-of-age from artificial intelligence to reducing mortality
por: Mehta, Puja, et al.
Publicado: (2022)

Baricitinib: the first immunomodulatory treatment to reduce COVID-19 mortality in a placebo-controlled trial
por: Kalil, Andre C, et al.
Publicado: (2021)

Wombat Roadkill Was Not Reduced by a Virtual Fence. Comment on Stannard et al. Can Virtual Fences Reduce Wombat Road Mortalities? Ecol. Eng. 2021, 172, 106414
por: Coulson, Graeme, et al.
Publicado: (2022)

Continuously protracted infusion of cisatracurium besilate in patients with ARDS
por: Yuan, Ziming, et al.
Publicado: (2022)

Mesenchymal Stem Cell Therapy for Severe COVID-19 ARDS
por: Häberle, Helene, et al.
Publicado: (2021)

Human Placental Mesenchymal Stem Cells for the Treatment of ARDS in Rat
por: Kakabadze, Zurab, et al.
Publicado: (2022)

Heterozygous POLG variant Ser1181Asn is associated with autosomal dominant neuro-myopathy in one family with no further specific manifestations of mitochondrial syndrome
por: Dohrn, Maike F., et al.
Publicado: (2022)

Hodgkin's lymphoma in developing countries: can we go further?()
por: Gaiolla, Rafael Dezen
Publicado: (2017)

Mesenchymal stromal cells reduce evidence of lung injury in patients with ARDS
por: Wick, Katherine D., et al.
Publicado: (2021)

Ketamine infusion as a sedative-analgesic in severe ARDS (KISS)
por: Pata, Ramakanth, et al.
Publicado: (2021)

The unaccomplished mission of reducing mortality in patients on kidney replacement therapy
por: Ortiz, Alberto
Publicado: (2020)

Mesenchymal stem cells: current clinical progress in ARDS and COVID-19
por: Xiao, Kun, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aq5gb2bq154atqo06jcfjehnt8